文献速递耳科与耳神经

耳科生物标志物鉴别梅尼埃病与前庭性偏头痛

Evaluating the Role of Otologic Biomarkers to Differentiate Meniere's Disease and Vestibular Migraine.
PubMed 文献 · Ear Hear · 2022-01-01

本研究为横断面队列研究,纳入19例梅尼埃病(MD)和11例前庭性偏头痛(VM)患者,评估prestin和otolin-1作为鉴别生物标志物的作用。MD组prestin均值2.33 ng/ml,VM组0.64 ng/ml(p=0.238);MD组otolin-1为109.67 pg/ml,VM组30.9 pg/ml(p=0.102)。MD患者中prestin水平与言语识别率相关,尤其当prestin>2 ng/ml时相关性最强(rho=0.9;p=0.019)。结论认为两种标志物在两组间有差异,但鉴别作用尚待阐明。

要点

  • MD与VM患者prestin和otolin-1水平有差异,但组间比较未达统计学显著。
  • MD患者中prestin水平与言语识别率相关,提示其可能反映内耳功能。
  • prestin和otolin-1用于鉴别MD与VM的价值仍需进一步研究。

核心结论

  • Prestin和otolin-1水平在MD与VM患者间存在差异,但鉴别两种疾病的作用尚未明确。

研究设计与样本

  • 横断面队列研究,纳入19例梅尼埃病患者和11例前庭性偏头痛患者。

主要发现

  • MD组prestin平均2.33 ng/ml,VM组0.64 ng/ml(p=0.238)。
  • MD组otolin-1平均109.67 pg/ml,VM组30.9 pg/ml(p=0.102)。
  • MD患者中prestin水平与言语识别率相关,prestin>2 ng/ml时相关性最强(rho=0.9;p=0.019)。

临床怎么用

  • prestin可能作为反映MD患者内耳功能的标志物,但不足以单独鉴别MD与VM。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the role for prestin and otolin-1 as biomarkers for differentiating Meniere's disease (MD) from vestibular migraine (VM). STUDY DESIGN: It is a cross-sectional, cohort study. RESULTS: There were 19 MD and 11 VM patients. In the 19 MD patients, the mean prestin level was 2.33 ng/ml compared to 0.64 ng/ml in VM patients (p = 0.238). Otolin-1 levels in MD patients were 109.67 pg/ml, while in VM patients, otolin-1 levels were 30.9 pg/ml (p = 0.102). In MD patients, prestin levels were correlated with word recognition scores, being strongest when prestin >2 ng/ml (rho = 0.9; p = 0.019). CONCLUSIONS: Prestin and otolin-1 levels differed between MD patients relative to VM patients. The relationship between prestin and word recognition scores in MD suggests that there may be a role for prestin as a marker for inner ear function, but its role in differentiating MD from VM remains to be elucidated.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Naples JG, Soda D, Rahman K, et al. Evaluating the Role of Otologic Biomarkers to Differentiate Meniere's Disease and Vestibular Migraine. Ear Hear. 2022. PMID: 34495899. doi:10.1097/AUD.0000000000001123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。